Synergetics · 4 weeks ago
Asset Strategy Leader - Surgical R+D
Bausch + Lomb is a leading global eye health company dedicated to protecting and enhancing sight. The Asset Strategy Leader will drive alignment and decision-making across multiple functions, guiding the creation and execution of asset strategies for device and capital equipment products throughout their lifecycle.
Health CareHealth DiagnosticsManufacturingMedical DevicemHealth
Responsibilities
Chair the relevant Project Strategy Core Team(s), Serve as the enterprise leader and primary point of contact for device asset strategy, representing the project to Governance and senior management
Develop and articulate integrated cross-functional Global Project Strategies for all aspects of device and capital equipment product development, commercialization, and lifecycle management, ensuring timely and comprehensive approvals
Review and analyze emerging data objectively to drive the team toward recommendations that highlight opportunities, address risks, and proactively provide appropriate mitigations
Collaborate with all functions to ensure programs are appropriately resourced, stay within allocated budgets, and champion requests for incremental resources when justified
Track progress against the Target Product Profile (TPP) ensuring alignment with committed timelines and budgets in conjunction with the Portfolio Project Manager
Continually validate the scientific and commercial viability of device programs, developing clear Go/No-Go decision points and championing the program with objectivity and sound judgment
Act as a strategic advisor to cross-functional teams (e.g., Global Commercial, R&D, Regulatory, Operations), ensuring alignment on key functional deliverables
Establish close, ongoing ties with all team members and supporting teams, empowering and delegating appropriately while maintaining aligned efforts and a function-neutral perspective
Represent the asset in external interactions (e.g., advisory boards, regulatory meetings) when broad leadership representation is required
Stay abreast of industry trends, emerging technologies, and competitive landscape in the device and capital equipment space, leveraging insights to inform strategy and execution
Coach and mentor team members, fostering a high-performance culture and developing future leaders
Excel at communication, ensuring clarity, transparency, and alignment across all levels of the organization
Qualification
Required
Bachelor's degree required; advanced (Doctoral-level or MBA) degree highly preferred
Minimum of 8 years of relevant experience as a leader in medical device or capital equipment Commercial, R&D, Regulatory, or Operations settings, ideally across multiple functions and global environments
Demonstrated experience in device product development, with particular emphasis on capital equipment, surgical devices, or ophthalmic technologies
Proven track record of leading cross-functional teams and driving complex device programs from concept through commercialization and lifecycle management
Deep understanding of device regulatory requirements (e.g., FDA 21 CFR Part 820, ISO 13485, IEC 60601), quality systems, and the integration of regulatory, clinical, and commercial strategies for device assets
Demonstrated ability to communicate with and influence senior executives
Strong analytical, strategic planning, and problem-solving skills, with the ability to assimilate new knowledge relevant to device development and commercialization
Ability to objectively exercise judgment, create pragmatic solutions to complex cross-functional problems, and be accountable for informed decision-making in the face of uncertainty or incomplete data
Passion for innovation in medical devices and a commitment to advancing patient outcomes through effective asset strategy leadership
Preferred
Experience following a single device asset or program through all phases of development and commercialization is preferred; aggregate experience across multiple assets is also valued
Benefits
Employee Benefits: Bausch + Lomb
Company
Synergetics
As Synergetics becomes Bausch + Lomb Retina, keep following us to learn why our newly formed partnership is all about you.
Funding
Current Stage
Public CompanyTotal Funding
unknown2016-02-10Acquired
1990-04-06IPO
Company data provided by crunchbase